Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Persistent loss of intrahepatic IFN-γ in HBV is linked to selective impairment of liver-resident CXCR6+NK cells despite long-term NUC therapy.

JHEP reports : innovation in hepatology·2026

Same author

A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells.

JHEP reports : innovation in hepatology·2026

Same author

Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study.

The Journal of infectious diseases·2026

Same author

Hepatic CD4 T Cells Predict Hepatocellular Carcinoma Risk on Metabolic Dysfunction-Associated Steatohepatitis Patients.

United European gastroenterology journal·2025

Same author

HBV Infection Drives PSMB5-Dependent Proteasomal Activation in Humanized Mice and HBV-Associated HCC.

Viruses·2025

Same author

Genetic Analysis of Metabolic-associated Steatosis Liver Disease in a Colombian Cohort.

Journal of clinical and experimental hepatology·2025

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Experimental models for hepatitis C viral infection.

Andre Boonstra¹, Luc J W van der Laan, Thomas Vanwolleghem

¹Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Hepatology (Baltimore, Md.)

|August 12, 2009

Summary

Hepatitis C virus (HCV) research has advanced significantly due to new cell culture and animal models. These models are crucial for understanding HCV infection and developing new antiviral treatments.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jun 21, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Area of Science:

Hepatology
Virology
Biomedical Research

Background:

Hepatitis C virus (HCV) infection is a primary cause of chronic liver disease, cirrhosis, and liver cancer.
Understanding HCV has been challenging due to a lack of effective model systems for research.
Recent advancements in in vitro and in vivo models have accelerated HCV research.

Purpose of the Study:

To provide an overview of current Hepatitis C virus (HCV) research models.
To discuss the limitations of existing HCV research models.
To outline future research directions for preventing and curing HCV.

Main Methods:

Review of in vitro cell culture systems for HCV research.
Analysis of in vivo small-animal models for HCV infection studies.
Evaluation of preclinical testing capabilities of these models for antiviral compounds.

Main Results:

Development of cell culture and small-animal models has significantly improved HCV research.
These models have led to breakthroughs in understanding HCV infection and replication.
Current models enable preclinical testing of novel antiviral therapies for chronic HCV.

Conclusions:

New in vitro and in vivo models have revolutionized Hepatitis C virus (HCV) research.
Continued development and refinement of these models are essential for advancing HCV prevention and cure.
Future research should focus on overcoming model limitations to accelerate the development of effective treatments.